Kuchyne na miru

Korean Biotech Talks About U.S. Company Launch

Jun 29, 2018

Enzychem Lifesciences’ Chairman and CEO, Ki-Young Sohn explains why the Korean biotech decided to open U.S. headquarters, as well as gives an update on their most recent clinical trials.

He spoke to Pharm Exec during a company event in New York City.

 

 

 

native1_300x100
https://pillsbank.net

www.pills24.com.ua

Купить Meizu X
lorem ipsum